Poor glucose control linked with longer hospital stay, higher costsJuly 14, 2015DiabetesEndocrinology
ADA: DPP4 inhibitors and cardiovascular outcomes: connecting the dotsJune 18, 2015DiabetesCardiologyEndocrinology
ELIXA trial: No cardiovascular risk with GLP-1 receptor agonist lixisenatideJune 9, 2015DiabetesCardiologyEndocrinology
FDA panel set to review two biologic lipid-lowering drugs for approvalJune 8, 2015CardiologyEndocrinology
Tight glycemic control: Somewhat fewer CV events, same mortalityJune 3, 2015DiabetesCardiologyEndocrinology
PAS: New approaches for cystic fibrosis–related diabetes in developmentMay 12, 2015DiabetesPediatricsEndocrinologyPulmonology
New guidelines address hypopituitarism in TBIMay 12, 2015EndocrinologyNeurologyTraumaHematologyMental Health
